ArticleClinical epigenetics2025

A liquid biopsy approach detects HCC and identifies GJA4 as a potential biomarker for HBV-HCC via plasma cfDNA methylome profiling.

Jialing Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.